Cystic fibrosis is one of the most common genetic disorders, causing thick mucus build-up in the lungs and other parts of the body, breathing problems, and infection. Now, researchers have developed a ...

A CRISPR gene-editing therapy has the potential to offer an effective, long-lasting treatment for cystic fibrosis after overcoming a major challenge that held back previous genetic therapies. The ...

PITTSBURGH--(BUSINESS WIRE)--Peptilogics, a biotech company that engineers peptide therapeutics to improve the treatment landscape for patients with life-threatening diseases, today announced that the ...

Care for patients with cystic fibrosis has undergone transformative changes over the past decade and serves as an example of how an understanding of the functional consequences of a genetic disease ...

Yale researchers have identified a possible driver of the persistent inflammation that causes irreversible lung damage in patients with cystic fibrosis, a genetic disorder that impairs breathing and ...

A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to deliver genetic therapies straight to lung cells. This innovation could transform ...

CLEVELAND, Ohio — Many patients with advanced cystic fibrosis — an illness that causes thick mucus secretions — turn to lung transplants to improve their quality of life. But in taking that step, they ...

Cystic fibrosis (CF) affects over 100,000 people worldwide and is caused by one of several known mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. The CFTR protein is a ...

Please provide your email address to receive an email when new articles are posted on . In patients with cystic fibrosis, lower preoperative BMI was linked to lower likelihood for BMI recovery within ...

Cystic fibrosis (CF) impairs both men and women’s fertility. Still, the chances of having biologi­cal children for individuals with CF have significantly improved due to break­throughs in fertility ...